Factors associated with corticosteroid use in Crohn's disease and ulcerative colitis patients in Israel: A multicenter cross-sectional study
- 29 January 2024
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 56 (5) , 744-748
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDGastroenterology, 2021
- ACG Clinical Guideline: Ulcerative Colitis in AdultsAmerican Journal of Gastroenterology, 2019
- A multi‐centre audit of excess steroid use in 1176 patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2017
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch DisordersJournal of Crohn's and Colitis, 2017
- Corticosteroid Use and Complications in a US Inflammatory Bowel Disease CohortPLOS ONE, 2016
- Prevalence of and Outcomes Associated with Corticosteroid Prescription in Inflammatory Bowel DiseaseInflammatory Bowel Diseases, 2014
- Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ RegistryAmerican Journal of Gastroenterology, 2012
- A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohnʼs disease and ulcerative colitisInflammatory Bowel Diseases, 2006
- The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based studyGastroenterology, 2001
- Cortisone in Ulcerative ColitisBMJ, 1954